Hsa_circ_0070269 inhibits hepatocellular carcinoma progression through modulating miR-182/NPTX1 axis
Xiaotong Su1, Jutong Su2, Hua He1
1Department of General Surgery, Luoyang Central Hospital Affiliated to Zhengzhou University, Luoyang, 471000, Henan, PR China.
Abstract:
Circular RNAs (circRNAs) have recently been shown to play critical roles in tumorigenesis. However, the roles of circRNAs in hepatocellular carcinoma (HCC) remain largely unknown. In the present study, we identified a novel circRNA (hsa_circ_0070269) was significantly decreased in HCC tissues and cell lines, low hsa_circ_0070269 expression was positively associated with advanced tumor stage, lymph node metastasis, and poor overall survival. Hsa_circ_0070269 overexpression suppressed proliferation and invasion of HCC cells in vitro and reduced tumor growth in vivo. Mechanistically, hsa_circ_0070269 increased NPTX1 expression via sponging miR-182 in HCC cells, which inhibited aggressive tumor behavior. Taken together, our findings suggest that hsa_circ_0070269 might play an important role in HCC development via miR-182/NPTX1 axis, therefore could serve as a potential therapeutic target for HCC treatment.
Insights
This study reveals that low levels of circular RNA (circRNA) hsa_circ_0070269 correlate with aggressive hepatocellular carcinoma (HCC). Restoring hsa_circ_0070269 inhibits HCC growth and metastasis.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Circular RNAs (circRNAs) are implicated in cancer development.
- The specific roles of circRNAs in hepatocellular carcinoma (HCC) are not well understood.
Purpose of the Study:
- To investigate the function of a novel circRNA, hsa_circ_0070269, in hepatocellular carcinoma (HCC).
- To explore the potential of hsa_circ_0070269 as a therapeutic target for HCC.
Main Methods:
- Quantitative real-time PCR to measure hsa_circ_0070269 expression in HCC tissues and cell lines.
- In vitro and in vivo experiments to assess the effects of hsa_circ_0070269 overexpression on HCC cell proliferation, invasion, and tumor growth.
- Mechanism studies involving microRNA (miR-182) and its target gene (NPTX1) to elucidate the regulatory pathway.
Main Results:
- Hsa_circ_0070269 was significantly downregulated in HCC tissues and cell lines.
- Low hsa_circ_0070269 expression correlated with advanced tumor stage, lymph node metastasis, and poorer overall survival.
- Overexpression of hsa_circ_0070269 suppressed HCC cell proliferation and invasion in vitro and reduced tumor growth in vivo.
- Hsa_circ_0070269 acts as a sponge for miR-182, leading to increased NPTX1 expression and inhibition of aggressive tumor behavior.
Conclusions:
- Hsa_circ_0070269 plays a crucial role in suppressing HCC development.
- The miR-182/NPTX1 axis is a key mechanism through which hsa_circ_0070269 exerts its tumor-suppressive effects.
- Hsa_circ_0070269 represents a potential therapeutic target for HCC treatment.
More Related Videos
Related Concept Videos
Abnormal Proliferation
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Hedgehog Signaling Pathway


